Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy

Evidence on the impact of COVID-19 vaccination on symptoms, Health-Related Quality of Life (HRQoL) and Work Productivity and Activity Impairment (WPAI) is scarce. We analyzed associations between bivalent BA.4/5 BNT162b2 (BNT162b2) and these patient-reported outcomes (PROs). Symptomatic US adults te...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Fusco, Manuela, Sun, Xiaowu, Anatale-Tardiff, Laura, Yehoshua, Alon, Coetzer, Henriette, Alvarez, Mary B., Allen, Kristen E., Porter, Thomas M., Puzniak, Laura, Lopez, Santiago M. C., Cappelleri, Joseph C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675533/
https://www.ncbi.nlm.nih.gov/pubmed/38006001
http://dx.doi.org/10.3390/vaccines11111669

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675533/
https://www.ncbi.nlm.nih.gov/pubmed/38006001
http://dx.doi.org/10.3390/vaccines11111669

Ejemplares similares